Vivo Capital, LLC Delcath Systems, Inc. Put Options Transaction History
Vivo Capital, LLC
- $472 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DCTH
# of Institutions
121Shares Held
13.2MCall Options Held
108KPut Options Held
40.5K-
Vanguard Group Inc Valley Forge, PA1.61MShares$17.5 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$8.84 Million0.25% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il803KShares$8.74 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA703KShares$7.65 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0483KShares$5.26 Million0.01% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $93.5M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...